We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

137 hedge funds and large institutions have $887M invested in Immunogen Inc in 2014 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 46 increasing their positions, 43 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

222% more call options, than puts

Call options by funds: $9.27M | Put options by funds: $2.88M

7% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 43

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

4% less funds holding

Funds holding: 142 → 137 (-5)

22% less capital invested

Capital invested by funds: $1.14B → $887M (-$251M)

23% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 22

Holders
137
Holders Change
-5
Holders Change %
-3.52%
% of All Funds
3.94%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
17
Increased
46
Reduced
43
Closed
22
Calls
$9.27M
Puts
$2.88M
Net Calls
+$6.38M
Net Calls Change
+$2.93M

Top Buyers

Rank Fund Capital Flow
1
ClearBridge Investments
ClearBridge Investments
New York
+$8.56M
2
Norges Bank
Norges Bank
Norway
+$7.16M
3
First Trust Advisors
First Trust Advisors
Illinois
+$6.44M
4
Morgan Stanley
Morgan Stanley
New York
+$6.4M
5
Renaissance Technologies
Renaissance Technologies
New York
+$5.21M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$22.8M
2
Invesco
Invesco
Georgia
-$10.9M
3
Primecap Management
Primecap Management
California
-$9.45M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$6.87M
5
SAM
Sectoral Asset Management
Quebec, Canada
-$5.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bessemer Group
126
Bessemer Group
New Jersey
$3K -$9.45K -753 -72%
MBT
127
Monroe Bank & Trust
Michigan
$2K – – –
US Bancorp
128
US Bancorp
Minnesota
$2K – – –
WA
129
Waverly Advisors
Alabama
$2K – – –
ECM
130
Estabrook Capital Management
New York
$1.61K +$1.71K +136 New
BNP Paribas Financial Markets
131
BNP Paribas Financial Markets
France
$1.17K +$728 +58 +141%
FWM
132
Focused Wealth Management
New York
$1K – – –
MFS
133
MSI Financial Services
Massachusetts
$1K – – –
NC
134
NewSquare Capital
Pennsylvania
$1K +$602 +48 New
JG
135
Jefferies Group
New York
$1K +$1.29K +103 New
VAM
136
Visionary Asset Management
Texas
$1K +$1.3K +104 New
Invesco
137
Invesco
Georgia
– -$10.9M -733,259 Closed
SFSIG
138
San Francisco Sentry Investment Group
California
– -$1.49M -100,000 Closed
PP
139
PDT Partners
New York
– -$907K -60,769 Closed
BACM
140
Blue Arrow Capital Management
New York
– -$672K -45,000 Closed
PCM
141
Prelude Capital Management
New York
– -$580K -38,823 Closed
SFM
142
Sphera Funds Management
Israel
– -$515K -34,500 Closed
ARTA
143
A.R.T. Advisors
New York
– -$511K -34,268 Closed
EMG
144
Ellington Management Group
Connecticut
– -$388K -26,000 Closed
Cambridge Investment Research Advisors
145
Cambridge Investment Research Advisors
Iowa
– -$274K -18,358 Closed
AG
146
Algert Global
California
– -$274K -18,320 Closed
WMSA
147
Weiss Multi-Strategy Advisers
New York
– -$217K -14,550 Closed
DC
148
Deere & Company
Illinois
– -$180K -12,064 Closed
Nomura Holdings
149
Nomura Holdings
Japan
– -$172K -11,467 Closed
DCMM
150
DG Capital Management (Massachusetts)
Massachusetts
– -$160K -10,740 Closed
3 4 5
6
7

IMGN Hedge Fund Activity: Q2 2014 in Review

137 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2014, worth a combined $887M — down 22% from $1.14B a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of IMGN and 17 opened new positions — a net loss of 5 holders — while 43 trimmed existing stakes and 46 added.

The largest buyer was ClearBridge Investments, adding an estimated $8.56M. The largest seller was Wellington Management Group, cutting an estimated $22.8M.

  • 137 institutional investors held Immunogen Inc (IMGN) as of Q2 2014, down from 142 in Q1 2014.
  • Funds reported $887M of Immunogen Inc stock for Q2 2014, down 22% quarter-over-quarter.
  • 17 funds opened new Immunogen Inc positions in Q2 2014 and 22 closed out, a net change of -5 holders.
  • The largest Immunogen Inc buyer in Q2 2014 was ClearBridge Investments, an estimated $8.56M added.
  • The largest Immunogen Inc seller in Q2 2014 was Wellington Management Group, an estimated $22.8M sold.

Based on aggregated 13F filings for Q2 2014.